Best Life Sciences Companies in Burlington, United States
The 35 best Life Sciences companies in Burlington, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Infraredx.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Burlington
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Infraredx Intravascular imaging pioneers improving coronary artery disease treatment and patient outcomes | $101M | 154 mo ago | Acquired | 59 | — | 147 patents Intravascular optical imaging catheters with force‑error detection and blood‑flow spectroscopy | — |
| 2 | RedShift Provider of tools for analytical testing 57Moat top 22%Funding top 25%Product top 26%Growth top 32% All 10 signals ▾Moattop 22% Fundingtop 25% Producttop 26% Growthtop 32% Techtop 34% Innovationtop 35% Newstop 41% Talentbottom 49% Marketbottom 34% Globalbottom 32% Moat: Editorial + unicorn rating 8/10 · Soonicorn Funding: Raised $89.4M across 12 rounds · 12 rounds over 20 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 57/100 | $89M | 15 mo ago | Series E | 28 28 → 26 (-7%) | Eugene Ma Co-founder & CTO | — | — |
| 3 | Keystone Dental Dental solutions provider: implants, biomaterials, prosthetics, instruments, and planning software | $86M | 135 mo ago | Acquired | 107 107 → 204 (+91%) | — | 47 patents Advanced dental implant abutments and internal connection systems for prosthetic stability. | — |
| 4 | Consano Bio Developer of biologic therapeutic engineered for orthopedic conditions treatment 35Funding top 28%Talent bottom 49%Global bottom 25% All 3 signals ▾Fundingtop 28% Talentbottom 49% Globalbottom 25% Funding: Raised $51.7M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 35/100 | $52M | 6 mo ago | Series C | — | Andrew Hall CEO | — | — |
| 5 | Epion Therapeutics Developer of minimally-invasive treatments for corneal ectatic diseases | $32M | 47 mo ago | Series A | — | Mike Webb Chief Executive Officer & Board Member | — | — |
| 6 | CoreMap Provider of platform to detect atrial fibrillation to manage heart disorders | $31M | 55 mo ago | Series B | 34 | Sarah O'Connell Kalil CEO | 22 patents High‑resolution cardiac electrophysiology mapping and bioelectric monitoring for arrhythmia diagnosis | — |
| 7 | General Oncology Developer of treatments for solid metastatic cancers and blood cancers 42Funding top 41%Patents top 42%Talent top 45%Innovation top 48% All 6 signals ▾Fundingtop 41% Patentstop 42% Talenttop 45% Innovationtop 48% Globalbottom 43% Techbottom 24% Funding: Raised $21.7M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) Patents: 26 patents matched (strict assignee match) · 17 filings since 2022 vs 9 in 2017-21 rank vs industry peers · Fliar Intelligence Index 42/100 | $22M | 5 mo ago | Series B | — | Arnold Glazier Founder | 26 patents Combination pharmaceutical regimens for treating metastatic cancer | — |
| 8 | Rhythmia Medical Medically licensed plant medicine retreat center offering holistic healing | $17M | 192 mo ago | Acquired | — | Leon Amariglio Founder & CEO | 138 patents Electroanatomical cardiac mapping using impedance-based anatomy and beat‑synchronization technologies | — |
| 9 | Heranova Lifesciences Developing diagnostics and treatments for womens health | $14M | 32 mo ago | Seed | — | Steve Landau Co-Founder | — | — |
| 10 | CorNova Range of endovascular products | $11M | 188 mo ago | Deadpooled | 2 | — | 76 patents Endoscopic fluid delivery and diagnostic/therapeutic devices for body lumens | — |
| 11 | LeMaitre Vascular Vascular surgery solutions innovator, improving patient lives with thoughtfully designed devices | $6M | 252 mo ago | Public | 317 | — | 32 patents Vascular surgical tools for valvulotomy and non‑occlusive arterial dilation/endarterectomy | — |
| 12 | Stromatec Devices for the diagnosis and treatment of connective tissue dysfunction | $4M | 192 mo ago | Deadpooled | — | David Churchill Co-Founder | — | — |
| 13 | TocopheRx Innovating oral infertility treatments for women and men, fostering parenthood | $3M | 153 mo ago | Seed | — | Stephen Palmer Co-Founder | 12 patents Small-molecule pyrazole modulators of the follicle-stimulating hormone receptor (FSHR) | — |
| 14 | Airing Revolutionary micro-CPAP device offering maskless, hoseless, cordless sleep apnea solution | $2M | 104 mo ago | Seed | 2 | Stephen Marsh Founder | — | — |
| 15 | Bionet Sonar Developer of wireless ultrasound based implants imaging devices | $1M | 76 mo ago | Funding Raised | — | Emrecan Demirors Co-Founder & Director | 18 patents Ultrasonic wireless power and data links for implantable medical devices | — |
| 16 | Visgo Therapeutics Delivering NSAID by sustained release for the treatment of knee osteoarthritis pain. | $725K | 138 mo ago | Deadpooled | — | Jeanne Bertonis Co-Founder and CEO | — | — |
| 17 | Samba Biologics Developer of biologic drugs for tissue preservation and repair after ischemic injury | $498K | 42 mo ago | Funding Raised | — | Dylan Ratigan Co-Founder & CEO | — | — |
| 18 | Formedix Clinical trial automation software and consultancy services based on CDISC standards. | $320K | 167 mo ago | Funding Raised | 50 | — | — | — |
| 19 | PafosPharma Developer of novel medications targeting the endocannabinoid system for therapeutic use | $225K | 90 mo ago | Funding Raised | — | Alexandros Makriyannis Founder | — | — |
| 20 | Atheric Pharmaceutical Reformulated drugs for infectious diseases | $100K | 120 mo ago | Deadpooled | — | Robert Malone Co-Founder & CEO | — | — |
| 21 | Auradonics Develops orthodontic products | — | — | Unfunded | — | John Ianieri Co-Founder & Owner | — | — |
| 22 | Azenta Provider of sample storage and management solutions | — | — | Public | 3,500 | Stephen Schwartz CEO & President | 81 patents Large-scale cryogenic biobanking: storage, handling, and tracking of biological samples | — |
Top 12 Life Sciences companies in Burlington
#1
Series C · Burlington, Massachusetts · founded 2023$51.7Mraised▾
Developer of biologic therapeutic engineered for orthopedic conditions treatment. The company focuses on developing a multi-protein therapeutic to target disease drivers. Its management team has experience in biologic drug development. The company's asset is for chronic lumbosacral radiculopathy.
- Mar 2026Series C$34.8M
- Oct 2024Series B$16.8M
#2
Series B · Burlington, Massachusetts · founded 2015$21.7Mraised▾
Developer of treatments for solid metastatic cancers and blood cancers. The company is developing combination chemotherapy for the treatment of BRCA-related metastatic cancers which include melphalan, BCNU (carmustine), hydroxocobalamin (vitamin B12b), and ascorbic acid (vitamin C) along with two stem cell transplants to reverse bone marrow suppression.
- Apr 2026Series B$4.8M
- Nov 2022Series B$6M
- Jun 2019Series B$10.9M
#3
Series E · Burlington, Massachusetts · founded 2005 · 28 employees$89.4Mraised▾
Redshift uses microfluidics modulation systems along with a tunable laser to develop analytical instruments for the detection of the very low level of analytes in the fluid. The technology can be applied in protein therapeutics detection where measurement of low concentration of the protein is critical. The instrument called ProLaser is used for lead candidate selection, preformulation and formulation development, process development optimization, and measuring and predicting stability, as well as for routine analytics, process monitoring, and QC release.
- Jun 2025Series E$5.9M
- Mar 2024Series E$5M
- Oct 2021Series E$20M
- Dec 2020Series D$6.4M
#4
Seed · Burlington, Massachusetts · founded 2022$13.5Mraised▾
Developing diagnostics and treatments for womens health, with a primary focus on endometriosis and bacterial vaginosis. It aims to enhance womens health by providing non invasive diagnostic solutions and treatments. It provides non invasive blood based test designed for the detection and confirmation of endometriosis. It aims to provide a solution to the diagnostic delays typically associated with the condition.
- Dec 2023Seed$13.5M
#5
Series B · Burlington, Massachusetts · founded 2017 · 34 employees$31.3Mraised▾
Provider of platform to detect atrial fibrillation to manage heart disorders. The company develops a cardiac electrophysiology mapping software that integrates with a diagnostic catheter to detect the patient's atrial fibrillation. The AF vitals help in better clinical decisions and health outcomes for the patients.
- Feb 2022Series B$20M
- Sep 2020Series A$10.5M
- Sep 2020Grant (prize money)$251.1K
- Sep 2020Grant (prize money)$251.1K
#6
Acquired · Burlington, North Carolina · founded 1998 · 59 employees$101Mraised▾
Intravascular imaging pioneers improving coronary artery disease treatment and patient outcomes. They are dedicated to conquering vascular disease through innovative solutions. They develop and provide high-resolution intravascular imaging platforms that combine structural views with plaque compositional analysis, offering treatment insights. Their products include HD-IVUS and IVUS+NIRS systems, along with essential accessories. They focus on identifying unstable lipid-core plaques to prevent major adverse cardiac events. They are involved in clinical research, conducting studies to evaluate the safety and effectiveness of their technologies. They aim to optimize the treatment of polyvascular disease patients. They provide educational resources, including webinar sessions and an IVUS app. They are committed to advancing clinical research and innovation in cardiovascular imaging and diagnostics. They are a medical device company focused on improving lives through innovative medical products.
- Nov 2013Conventional Debt$20M
- Aug 2013Series C$25M
- Dec 2011Conventional Debt$10M
- Jun 2011Series C$24.2M
#7
Series A · Burlington, Massachusetts · founded 2012$32Mraised▾
Developer of minimally-invasive treatments for corneal ectatic diseases. It develops a transformative cross-linking system to treat keratoconus without disrupting the epithelium, enabling rapid recovery. It allows simultaneous treatment of both eyes, eliminating the need for further deterioration. It is supported by experts in the field, utilizing advanced diagnostic tools to identify keratoconus progression early.
- Sep 2022Series A$32M
#8
Acquired · Burlington, Massachusetts · founded 2006 · 107 employees$86.2Mraised▾
Dental solutions provider: implants, biomaterials, prosthetics, instruments, and planning software. The company delivers advanced and easy-to-use solutions for dental professionals. Focused on providing functional and aesthetically pleasing outcomes, the company offers a range of products including anterior, posterior, and full arch solutions, as well as tissue regeneration materials. The eShop provides a convenient way to browse and order products. The company focuses on caring, simplicity, and trust, offering high-quality solutions with integrity. The company provides resources such as a resource center, digital libraries, references, forms, and IFUs. The website offers features like login, search, and a cart for easy navigation and shopping. The company is committed to education, offering tuition discounts to in-person global and local events.
- May 2015Series C$10.8M
- Mar 2015Series C$5.3M
- Jun 2013Series C$5M
- Oct 2012Series C$12M
#9
Acquired · Burlington, Massachusetts · founded 2004$16.6Mraised▾
Medically licensed plant medicine retreat center offering holistic healing. It is a full-service, short-stay, licensed medical center specializing in plant-based alternative therapies. The center offers retreats with plant medicine ceremonies, blending ancient practices with modern therapies for personal growth and transformation. The program combines ceremonies, yoga, meditation, and breathwork with modern psychology. Guests can experience premium amenities, gourmet organic meals, and a supportive environment. The center focuses on healing the mind, body, and soul through integrative classes and practices. The website offers features like "Book Now", pricing details, thought leader calendar, testimonials, reviews, blog, webinars, contact information, and media presence. The center aims to provide a safe and nurturing environment for self-discovery and healing.
- Sep 2010Series C$5M
- Mar 2010Series C$2.7M
- Aug 2009Grant (prize money)$221.4K
- Feb 2009Grant (prize money)$180K
#10
Deadpooled · Burlington, Massachusetts · founded 2003 · 2 employees$10.9Mraised▾
CorNova develops endovascular products. Key products include FiberHalo, a stent deployment catheter and CE-marked stent Valecor Platinum. Also has a presence in Germany and Argentina.
- Jan 2011Series A$385K
- Jan 2010Series A$2.5M
- Dec 2009Series A$5M
- Apr 2005Series A$3M
#11
Public · Burlington, Massachusetts · founded 1983 · 317 employees$5.8Mraised▾
Vascular surgery solutions innovator, improving patient lives with thoughtfully designed devices. The company provides surgeons and interventionalists worldwide with innovative devices and information to diagnose and heal the sick. They offer a range of products for aortic, cardiac, carotid, lower extremity, and neurovascular procedures. The company emphasizes a close working relationship with practitioners to bring innovative products and techniques to market. Their mission is focused on customer satisfaction, employee well-being, and stockholder value. They foster a collaborative spirit and a culture of mutual respect and support. The company is committed to providing effective therapeutic devices and techniques to meet the needs of surgeons and interventionalists, ultimately improving patient outcomes in vascular surgery.
- Sep 2005Series A$25K
- Aug 2005Series A$2.2M
- Feb 2005Series A$2.1M
- 2004Unattributed$200K
#12
Deadpooled · Burlington, Vermont · founded 2003$4.5Mraised▾
Stromatec develops devices for the diagnosis and treatment of connective tissue dysfunction such as chronic pain, scarring, or impaired mobility. Products developed by the company include Acusensor (measure, document, and analyze the needling component of treatment), StromaTorque (uses needle torque measurements to determine the cause of chronic pain), and StromaGlide (uses needle stimulation and ultrasound elastography to determine the cause of chronic pain).
- Aug 2010Grant (prize money)$750K
- Jun 2010Grant (prize money)$1.3M
- Mar 2010Grant (prize money)$243.3K
- May 2009Grant (prize money)$741.6K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.